Diagnostic and Prognostic Utility of PD-1 In B Cell Lymphomas

Por Muenst, S., Hoeller, S., Willi, N., Dirnhofer, S., Tzankov, A.
Publicado em 2010

The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer

Por Muenst, S., Soysal, S. D., Gao, F., Obermann, E. C., Oertli, D., EGillanders, W.
Publicado em 2013

PTP1B expression is an independent positive prognostic factor in human breast cancer

Por Soysal, S., Obermann, E. C., Gao, F., Oertli, D., Gillanders, W. E., Viehl, C. T., Muenst, S.
Publicado em 2012

Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38...

Por Tzankov, Alexandar, Leu, Nora, Muenst, Simone, Juskevicius, Darius, Klingbiel, Dirk, Mamot, Christoph, Dirnhofer, Stephan
Publicado no J Hematol Oncol (2015)

Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer

Por Jasmin Zeindler, Savas Deniz Soysal, Savas Deniz Soysal, Salvatore Piscuoglio, Salvatore Piscuoglio, Charlotte K. Y. Ng, Robert Mechera, Robert Mechera, Andrej Isaak, Walter Paul Weber, Simone Muenst, Simone Muenst, Christian Kurzeder, Christian Kurzeder
Publicado em 2019-09-01

SHP2 expression is an independent negative prognostic factor in human breast cancer

Por Muenst, S, Obermann, EC, Gao, F, Oertli, D, Viehl, CT, Weber, WP, Fleming, T, Gillanders, WE, Soysal, SD
Publicado em 2013

Applicability of second-generation upcyte® human hepatocytes for use in CYP inhibition and induction studies

Por Ramachandran, Sarada D, Vivarès, Aurélie, Klieber, Sylvie, Hewitt, Nicola J, Muenst, Bernhard, Heinz, Stefan, Walles, Heike, Braspenning, Joris
Publicado no Pharmacol Res Perspect (2015)

EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer

Por Soysal, S D, Muenst, S, Barbie, T, Fleming, T, Gao, F, Spizzo, G, Oertli, D, Viehl, C T, Obermann, E C, Gillanders, W E
Publicado em 2013

Nuclear Expression of Snail Is an Independent Negative Prognostic Factor in Human Breast Cancer

Por Muenst, S., Däster, S., Obermann, E. C., Droeser, R. A., Weber, W. P., von Holzen, U., Gao, F., Viehl, C., Oertli, D., Soysal, S. D.
Publicado em 2013

Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer

Por Muenst, S., Schaerli, A. R., Gao, F., Däster, S., Trella, E., Droeser, R. A., Muraro, M. G., Zajac, P., Zanetti, R., Gillanders, W. E., Weber, W. P., Soysal, S. D.
Publicado em 2014

Identification and translational validation of novel mammaglobin-A CD8 T cell epitopes

Por Soysal, S. D., Muenst, S., Kan-Mitchell, J., Huarte, E., Zhang, X., Wilkinson-Ryan, I., Fleming, T., Tiriveedhi, V., Mohanakumar, T., Li, L., Herndon, J., Oertli, D., Goedegebuure, S. P., Gillanders, W. E.
Publicado no Breast Cancer Res Treat (2014)

Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol fo...

Por Guido Henke, Michael Knauer, Karin Ribi, Stefanie Hayoz, Marie-Aline Gérard, Thomas Ruhstaller, Daniel R. Zwahlen, Simone Muenst, Markus Ackerknecht, Hanne Hawle, Florian Fitzal, Michael Gnant, Zoltan Mátrai, Bettina Ballardini, Andreas Gyr, Christian Kurzeder, Walter P. Weber
Publicado em 2018-12-01